Trial Profile
Phase 2 Clinical Trial of Bardoxolone Methyl (RTA 402) in Patients with Chronic Kidney Disease and Type 2 Diabetes
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 09 Feb 2015
Price :
$35
*
At a glance
- Drugs Bardoxolone methyl (Primary)
- Indications Diabetic nephropathies
- Focus Therapeutic Use
- Sponsors Kyowa Kirin
- 09 Feb 2015 New trial record